ArticleFrontiers in pharmacology2025

The development and evaluation of a tublysine-based antibody-drug conjugate with enhanced tumor therapeutic efficacy.

Huihui Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.